Search Results - "Rudeen, Kayla"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Advances in ocular drug delivery systems by Kang-Mieler, Jennifer J., Rudeen, Kayla M., Liu, Wenqiang, Mieler, William F.

    Published in Eye (London) (01-08-2020)
    “…Recent advances in pharmacological agents have led to successful treatment of a variety of retinal diseases such as neovascular age-related macular…”
    Get full text
    Journal Article
  2. 2

    Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery System by Rudeen, Kayla M., Liu, Wenqiang, Mieler, William F., Kang-Mieler, Jennifer J.

    Published in Current eye research (03-07-2022)
    “…Intravitreal injections of anti-vascular endothelial growth factors (anti-VEGF) are the current standard of care for patients with choroidal neovascularization…”
    Get full text
    Journal Article
  3. 3

    Treatment Efficacy and Biocompatibility of a Biodegradable Aflibercept-Loaded Microsphere-Hydrogel Drug Delivery System by Liu, Wenqiang, Tawakol, Anessa Puskar, Rudeen, Kayla M, Mieler, William F, Kang-Mieler, Jennifer J

    Published in Translational vision science & technology (01-10-2020)
    “…To evaluate the in vivo treatment efficacy and biocompatibility of a biodegradable aflibercept-loaded microsphere-hydrogel drug delivery system (DDS) in a…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Simultaneous Release of Bioactive Aflibercept and Dexamethasone from a Microsphere- and Nanoparticle-Hydrogel Ocular Drug Delivery System for the Enhanced Treatment of Non-responsive Patients with Choroidal Neovascularization by Rudeen, Kayla M

    Published 01-01-2022
    “…There is a growing subset of wet age-related macular degeneration (AMD) patients who do not fully respond to standard of care treatment, which consists of…”
    Get full text
    Dissertation